BioInvent International AB Cash Flow-to-Debt Ratio
BioInvent International AB cash flow-to-debt ratio. BioInvent International AB (BINV) has a Cash Flow-to-Debt Ratio of 0.63x as of June 2025, meaning its operating cash flow of Skr66.78 Million could theoretically repay 1% of its total liabilities (Skr105.93 Million) in one year. Check earnings quality score of BioInvent International AB to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of BioInvent International AB (2002–2024)
Cash flow-to-debt ratio of BioInvent International AB from 2002 to 2024. Historical debt coverage capacity for BioInvent International AB across 23 annual periods. Check BINV cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
BioInvent International AB Cash Flow-to-Debt Ratio by Year (2002–2024)
BioInvent International AB cash flow-to-debt ratio by year from 2002 to 2024. Year-by-year debt coverage analysis for BioInvent International AB. For the full cash flow conversion analysis, see BioInvent International AB operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.68x | Skr-380.47 Million | Skr103.42 Million | ▲ +2.6% |
| 2023 | -3.78x | Skr-341.69 Million | Skr90.45 Million | ▼ -872.1% |
| 2022 | -0.39x | Skr-41.23 Million | Skr106.09 Million | ▲ +87.3% |
| 2021 | -3.06x | Skr-245.84 Million | Skr80.32 Million | ▼ -189.1% |
| 2020 | -1.06x | Skr-62.62 Million | Skr59.14 Million | ▲ +52.2% |
| 2019 | -2.21x | Skr-125.43 Million | Skr56.67 Million | ▲ +48.7% |
| 2018 | -4.31x | Skr-141.39 Million | Skr32.78 Million | ▼ -126.4% |
| 2017 | -1.91x | Skr-75.88 Million | Skr39.82 Million | ▼ -21.3% |
| 2016 | -1.57x | Skr-72.05 Million | Skr45.86 Million | ▲ +45.9% |
| 2015 | -2.90x | Skr-72.57 Million | Skr24.99 Million | ▲ +17.2% |
| 2014 | -3.51x | Skr-76.03 Million | Skr21.68 Million | ▼ -108.1% |
| 2013 | -1.69x | Skr-54.65 Million | Skr32.43 Million | ▲ +31.8% |
| 2012 | -2.47x | Skr-170.38 Million | Skr68.92 Million | ▼ -202.3% |
| 2011 | -0.82x | Skr-55.45 Million | Skr67.81 Million | ▲ +55.6% |
| 2010 | -1.84x | Skr-117.70 Million | Skr63.84 Million | ▼ -2.4% |
| 2009 | -1.80x | Skr-127.14 Million | Skr70.61 Million | ▼ -364.1% |
| 2008 | 0.68x | Skr43.73 Million | Skr64.13 Million | ▲ +207.2% |
| 2007 | 0.22x | Skr12.63 Million | Skr56.88 Million | ▲ +108.4% |
| 2006 | -2.65x | Skr-101.23 Million | Skr38.18 Million | ▼ -19.0% |
| 2005 | -2.23x | Skr-105.48 Million | Skr47.34 Million | ▲ +35.4% |
| 2004 | -3.45x | Skr-88.74 Million | Skr25.73 Million | ▼ -99.1% |
| 2003 | -1.73x | Skr-66.25 Million | Skr38.23 Million | ▼ -755.2% |
| 2002 | -0.20x | Skr-10.57 Million | Skr52.16 Million | — |